Improving mental health care in depression: A call for action.
Future trends inpsychiatry
depressive disorders
policy paper
political framework
Journal
European psychiatry : the journal of the Association of European Psychiatrists
ISSN: 1778-3585
Titre abrégé: Eur Psychiatry
Pays: England
ID NLM: 9111820
Informations de publication
Date de publication:
03 08 2023
03 08 2023
Historique:
medline:
11
9
2023
pubmed:
3
8
2023
entrez:
3
8
2023
Statut:
epublish
Résumé
Depressive disorders have one of the highest disability-adjusted life years (DALYs) of all medical conditions, which led the European Psychiatric Association to propose a policy paper, pinpointing their unmet health care and research needs. The first part focuses on what can be currently done to improve the care of patients with depression, and then discuss future trends for research and healthcare. Through the narration of clinical cases, the different points are illustrated. The necessary political framework is formulated, to implement such changes to fundamentally improve psychiatric care. The group of European Psychiatrist Association (EPA) experts insist on the need for (1) increased awareness of mental illness in primary care settings, (2) the development of novel (biological) markers, (3) the rapid implementation of machine learning (supporting diagnostics, prognostics, and therapeutics), (4) the generalized use of electronic devices and apps into everyday treatment, (5) the development of the new generation of treatment options, such as plasticity-promoting agents, and (6) the importance of comprehensive recovery approach. At a political level, the group also proposed four priorities, the need to (1) increase the use of open science, (2) implement reasonable data protection laws, (3) establish ethical electronic health records, and (4) enable better healthcare research and saving resources.
Identifiants
pubmed: 37534402
doi: 10.1192/j.eurpsy.2023.2434
pii: S0924933823024343
pmc: PMC10486253
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e65Références
Curr Psychiatry Rep. 2022 Sep;24(9):407-417
pubmed: 35835898
Arch Gen Psychiatry. 2005 Apr;62(4):409-16
pubmed: 15809408
J Neurosci. 2021 Feb 3;41(5):891-900
pubmed: 33257322
Brain Sci. 2022 Mar 14;12(3):
pubmed: 35326343
JAMA Psychiatry. 2020 Sep 1;77(9):889-890
pubmed: 32459326
Sci Stat Database Manag. 2013;:
pubmed: 24401992
BMC Psychiatry. 2020 Dec 14;20(1):591
pubmed: 33317480
Mol Psychiatry. 2021 Jan;26(1):118-133
pubmed: 32704061
J Affect Disord. 2022 Jan 1;296:17-25
pubmed: 34583099
World Psychiatry. 2017 Feb;16(1):30-40
pubmed: 28127922
J Med Internet Res. 2022 Feb 9;24(2):e31146
pubmed: 35138261
Lancet. 2018 Nov 24;392(10161):2299-2312
pubmed: 30396512
Am Fam Physician. 2018 Oct 15;98(8):508-515
pubmed: 30277728
Technol Health Care. 2017;25(1):1-10
pubmed: 27689562
J Affect Disord. 2020 Jan 15;261:160-163
pubmed: 31630037
BMC Fam Pract. 2018 Jun 23;19(1):99
pubmed: 29935537
JAMA Psychiatry. 2021 Feb 1;78(2):121-122
pubmed: 32725172
Epidemiol Psychiatr Sci. 2019 Apr 05;29:e30
pubmed: 30947759
Psychiatry Investig. 2021 Jan;18(1):1-10
pubmed: 33321557
Lancet. 2007 Sep 29;370(9593):1164-74
pubmed: 17804061
Nat Rev Neurosci. 2010 Sep;11(9):642-51
pubmed: 20717121
Eur Psychiatry. 2008 Jan;23 Suppl 1:1-3
pubmed: 18371572
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:287-94
pubmed: 23085507
Brain Stimul. 2022 Mar-Apr;15(2):523-531
pubmed: 35337598
N Engl J Med. 2008 Apr 17;358(16):1738-40
pubmed: 18420507
Neuropsychopharmacology. 2021 Jun;46(7):1293-1299
pubmed: 33479508
PLoS One. 2012;7(7):e40089
pubmed: 22792217
Psychol Psychother. 2019 Jun;92(2):164-189
pubmed: 30932302
Int J Environ Res Public Health. 2021 Sep 14;18(18):
pubmed: 34574593
Schizophr Bull. 2021 Mar 16;47(2):284-297
pubmed: 32914178
Depress Anxiety. 2021 Apr;38(4):400-411
pubmed: 33615617
Clin Neurophysiol. 2017 Nov;128(11):2318-2329
pubmed: 29040922
World Psychiatry. 2021 Jun;20(2):154-170
pubmed: 34002503
BMC Res Notes. 2017 Sep 7;10(1):458
pubmed: 28882194
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 8;105:110139
pubmed: 33068682
BMJ Open. 2020 Dec 28;10(12):e038457
pubmed: 33372070
BMC Public Health. 2022 Dec 23;22(1):2420
pubmed: 36564745
J Affect Disord. 2015 Apr 1;175:53-65
pubmed: 25594512
Risk Manag Healthc Policy. 2011;4:47-55
pubmed: 22312227
J Clin Psychiatry. 2007;68 Suppl 2:3-9
pubmed: 17288501
JAMA Psychiatry. 2021 Apr 1;78(4):361-371
pubmed: 33471111
J Affect Disord. 2023 Feb 1;322:205-211
pubmed: 36372129
Lancet. 2009 Aug 22;374(9690):609-19
pubmed: 19640579
Lancet. 2007 Sep 8;370(9590):841-50
pubmed: 17826169
Psychiatr Serv. 2007 Aug;58(8):1036-8
pubmed: 17664512
J Am Pharm Assoc (2003). 2013 Mar-Apr;53(2):172-81
pubmed: 23571625
Evid Based Med. 2013 Jun;18(3):90-2
pubmed: 22923708
Lancet. 2022 Mar 5;399(10328):957-1022
pubmed: 35180424
Am J Med. 2013 Oct;126(10):853-7
pubmed: 24054954
BMC Med. 2019 Feb 15;17(1):31
pubmed: 30764826
Br Med Bull. 2018 Dec 1;128(1):109-118
pubmed: 30445448
Int J Psychiatry Clin Pract. 2021 Mar;25(1):19-27
pubmed: 32852246
Trends Pharmacol Sci. 2021 Nov;42(11):929-942
pubmed: 34565579
Med Teach. 2014 Mar;36(3):201-7
pubmed: 24256109
Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Mar;3(3):223-230
pubmed: 29486863
Int Rev Psychiatry. 2013 Feb;25(1):52-64
pubmed: 23383667
J Affect Disord. 2019 Oct 1;257:477-485
pubmed: 31319339
J Psychiatr Res. 2018 Aug;103:120-133
pubmed: 29843003
Healthc Manage Forum. 2019 Mar;32(2):56-62
pubmed: 30739487
J Psychiatr Res. 2013 Aug;47(8):1080-7
pubmed: 23684549